Product Details
Product Name:
dCeMM1 |
CAS No.:
118719-16-7 |
Purity:
99.52% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | dCeMM1 |
Description | dCeMM1, a RBM39 glue degrader, re-directs the activity of the CRL4DCAF15 ligase and decreases RBM39 expression levels in WT KBM7 cells. |
In vitro | dCeMM1 (0-100 μM; 3 days) inhibited cell growth with EC50 values of 3 and 8 μ M for WT and UBE2Mmut KBM7 cells, respectively, and at 10 μ M for 12-16 hours, it reduced RBM39 expression in WT KBM7 cells [1]. |
Storage | Shipping with blue ice. |
Solubility Information | DMSO : 1.8 mg/mL (4.9 mM)
|
Keywords | dCeMM1 |
Inhibitors Related | Eragidomide | PT-179 | Mezigdomide | dCeMM2 | FPFT-2216 | Thalidomide | Pomalidomide | Lenalidomide | Lenalidomide hemihydrate | HQ461 |
Related Compound Libraries | Bioactive Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:548-37-8
$30.00 / 1mg
-
CAS:1807518-72-4
$37.00 / 5mg
-
CAS:395683-14-4
$30.00 / 25mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |